Cite
Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review
MLA
Megan M. Kelly, et al. “Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review.” Journal of Dual Diagnosis, vol. 17, no. 3, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f187a1ffc91a8352afda9b7a1fac6603&authtype=sso&custid=ns315887.
APA
Megan M. Kelly, Shane W. Kraus, Steven D. Shirk, Nitigna Desai, Victoria Ameral, Joseph R. Houchins, Kendra Pugh, & Erin D. Reilly. (2021). Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review. Journal of Dual Diagnosis, 17(3).
Chicago
Megan M. Kelly, Shane W. Kraus, Steven D. Shirk, Nitigna Desai, Victoria Ameral, Joseph R. Houchins, Kendra Pugh, and Erin D. Reilly. 2021. “Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review.” Journal of Dual Diagnosis 17 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f187a1ffc91a8352afda9b7a1fac6603&authtype=sso&custid=ns315887.